We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Drug-Eluting Stents during ST-Segment Elevation Acute Myocardial Infarction: A Critical Analysis.
- Authors
DE ANDRADE, PEDRO BERALDO; TEBET, MARDEN ANDRÉ; MAIA DA SILVA, FELIPE SOUZA; ATHANAZIO DE ANDRADE, MÔNICA VIEIRA; LABRUNIE, ANDRÉ; PIVA E MATTOS, LUIZ ALBERTO
- Abstract
Primary percutaneous coronary intervention is the preferred reperfusion therapy for ST-segment elevation acute myocardial infarction patients within 12 hours of symptom-onset. Routine stent implantation during the procedure significantly reduces the rate of target vessel revascularization, although restenosis still represents a current limitation of the technique. Drug-eluting stents were developed to treat and prevent coronary restenosis. Randomized trials, meta-analysis, and registries proved their efficacy and safety in different clinical situations, including acute myocardial infarction. However, the increased risk of late stent thrombosis associated with drug-eluting stents during primary percutaneous coronary interventions encourages a careful analysis to identify which patients most benefit from them, as well as those where a prolonged dual antiplatelet therapy does not represent a limiting factor. (J Interven Cardiol 2011;24:416-423)
- Publication
Journal of Interventional Cardiology, 2011, Vol 24, Issue 5, p416
- ISSN
0896-4327
- Publication type
Academic Journal
- DOI
10.1111/j.1540-8183.2011.00650.x